Search By Initial

Cas Index 2

• 2274723-90-7 | SPG-302 (Catalog# : 24065)Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi
• 2226636-04-8 | soquelitinib (Catalog# : 20671)
• 2222138-31-8 (HCl) | Sotuletinib HCl (Catalog# : 20663)Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor.
• 2383086-06-2 | Sonrotoclax (BGB-11417) (Catalog# : 20650)Sonrotoclax is an antineoplastic.
• 2546091-70-5 | SOP1812 (QN-302) (Catalog# : 20639)QN-302 is a G-quadruplex (G4)-selective transcription inhibitor.
• 2883540-92-7 | STX-478 (Catalog# : 20633)STX-478 is a second generation, mutant-selective, oral PI3Ka small molecule allosteri
• 256414-75-2 | SEW2871 (Catalog# : 20604)SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871
• 2765525-82-2 | STX-721 (Catalog# : 20576)STX-721 is a next-generation, orally delivered therapy, designed with potential best-
• 2648257-56-9 | STC-15 (Catalog# : 20549)STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me
• 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol (Catalog# : 20522)
• 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester (Catalog# : 20412)
• 2322245-42-9 (free base) | SRI-37330 free base (Catalog# : 1711224)SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and
• 2370013-12-8 | Sunvozertinib ( DZD 9008 ) (Catalog# : 20369)Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective
• 2102681-49-0 | SHMT-IN-2 (Catalog# : 20368)SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting
• 2582757-90-0 | Stafia-1 (Catalog# : L20338)
• 2499663-01-1 | STM2457 (Catalog# : 20321)STM2457 is a highly potent and selective first-in-class catalytic inhibitor of METTL3
• 2322245-49-6 | SRI-37330 HCl (Catalog# : 20306)SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently
• 2089251-47-6 | SM-102 (Catalog# : 21252)SM-102 is an ionizable amino lipid that has been used in combination with other lipid
• 287383-59-9 | Scriptaid (Catalog# : 21229)Scriptaid, also known as GCK 1026, is a HDAC inhibitor. Scriptaid protects against tr
• 2301974-60-5 | (S)-3-(4,6-bis(((R)-1,1,1-trifluoropropan-2-yl)amino)- 1,3,5-triazin-2-yl)-2,6,6-trifluorocyclohex-2-en-1-ol (Catalog# : 20123103)
• 2351882-11-4 | Spastazoline (Catalog# : 2071521)Spastazoline is a novel inhibitor for aaa+ (atpases associated with diverse cellular
• 296280-56-3 | S26131 (Catalog# : 112592)S26131 is a bioactive chemical.
• 2195361-33-0 | SPL-707 (Catalog# : 193209)SPL-707 is the first selective and orally active SPPL2a inhibitor. It shows adequate
• 2055757-40-7 | SHP394 (Catalog# : 193122)SHP394 is a potent and orally active SHP2 inhibitor (IC50 = 23 nM) with high lipophil
• 2226517-76-4 | SGC-GAK-1 (Catalog# : 193113)SGC-GAK-1 is a potent and selective GAK kinase probe which targets the ATP-binding si
• 2152628-33-4 | Selpercatinib (Catalog# : 192276)Selpercatinib is a tyrosine kinase inhibitor with antineoplastic properties.
• 254740-64-2 | Sparsentan (Catalog# : 1812132)Sparsentan, also known as RE-021, PS433540 and DARA-a, is a Dual angiotensin II and e
• 2134602-45-0 | SR-17018 (Catalog# : 187166)SR17018 is an mu-opioid-receptor (MOR) agonist with an EC50 of 97 nM.
• 205678-31-5 | SB-273005 (Catalog# : 186221)SB-273005 is an inhibitor of integrin αvβ3.
• 2097334-20-6 | (S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic acid (Catalog# : 183218)(S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic aci